Home >> Signaling Pathways >> DNA Damage/DNA Repair >> Antifolate

Antifolate

<div class="colum_1 clearer"><p>Antifolates are compounds that antagonise the actions of folic acid (vitamin B9). Folic acid's primary function in the body is as a cofactor to various methyltransferases involved in serine, methionine, thymidine and purine biosynthesis. Consequently antifolates inhibit cell division, DNA/RNA synthesis and repair and protein synthesis. Some such as Proguanil, Pyrimethamine and Trimethoprim selectively inhibit folate's actions in microbial organisms such as bacteria, protozoa and fungi. The majority of antifolates work by inhibiting dihydrofolate reductase (DHFR). Many are primarily DHFR inhibitors, but Raltitrexed is an inhibitor of thymidylate synthase, and Pemetrexed inhibits both and a third enzyme. Antifolates act specifically during DNA and RNA synthesis, and thus are cytotoxic during the S-phase of the cell cycle. Thus, they have a greater toxic effect on rapidly dividing cells.</p></div>

Targets for  Antifolate

Products for  Antifolate

  1. Cat.No. Product Name Information
  2. GC42789 Aminopterin

    4-amino Folic Acid, 4-amino PGA, APGA, NSC 739

    Aminopterin is a synthetic folic acid derivative whose metabolite is a competitive inhibitor of dihydrofolate reductase, which is a cofactor for nucleic acid synthesis. Aminopterin  Chemical Structure
  3. GC15306 Calcium N5-methyltetrahydrofolate Calcium salt of levomefolic acid Calcium N5-methyltetrahydrofolate  Chemical Structure
  4. GC34309 Cycloguanil D6 (Chlorguanide triazine D6) Cycloguanil D6 (Chlorguanide triazine D6)  Chemical Structure
  5. GC35781 Cycloguanil D6 Nitrate

    Chlorguanide triazine D6 Nitrate

    Cycloguanil D6 Nitrate is the deuterium labeled Cycloguanil, which is a dihydrofolate reductase inhibitor. Cycloguanil D6 Nitrate  Chemical Structure
  6. GC65617 DHFR-IN-3 DHFR-IN-3 is a dihydrofolate reductase (DHFR) inhibitor with the IC50 values of 19 μM and 12 μM in rat liver and P. carinii DHFR, respectively. DHFR-IN-3  Chemical Structure
  7. GC32343 Diaveridine (EGIS-5645)

    NSC 408735

    Diaveridine (EGIS-5645) (EGIS-5645) is a dihydrofolate reductase (DHFR) inhibitor with a Ki of 11.5 nM for the wild type DHFR and also an antibacterial agent. Diaveridine (EGIS-5645)  Chemical Structure
  8. GC19495 DL-Folinic Acid (calcium salt)

    DL-Folinate NSC 3590

    DL-Folinic Acid (calcium salt) (Leucovorin calcium) is a biological folic acid and is generally administered along with methotrexate (MTX) as a rescue agent to decrease MTX-induced toxicity. DL-Folinic Acid (calcium salt)  Chemical Structure
  9. GC32401 EC0489 EC0489, a conjugate of folic acid and desacetyl vinblastine hydrazide, is a high-affinity ligand for the folate receptor (FR). Refractory or metastatic Tumor. Small molecule-drug conjugate (SMDC). EC0489  Chemical Structure
  10. GC62968 Fanotaprim

    VYR-006

    Fanotaprim is a dihydrofolate reductase (DHFR) inhibitor with IC50s of 1.57 and 308 nM for tgDHFR (Toxoplasma gondii DHFR) and hDHFR (human DHFR), respectively. Fanotaprim  Chemical Structure
  11. GC14331 Folinic acid NULL Folinic acid  Chemical Structure
  12. GC16203 Leucovorin Calcium Leucovorin Calcium (Leucovorin calcium salt pentahydrate) is a biological folic acid and is generally administered along with methotrexate (MTX) as a rescue agent to decrease MTX-induced toxicity. Leucovorin Calcium  Chemical Structure
  13. GC16680 Levoleucovorin Calcium

    L-Folinate, 5-Formyltetrahydrofolate

    Levoleucovorin Calcium (Calcium levofolinate), a levo isoform of Leucovorin Calcium, possesses antineoplastic effects. Levoleucovorin Calcium is also an augmentor of 5-fluorouracil cytotoxicity against cancer. Levoleucovorin Calcium  Chemical Structure
  14. GC11558 Levomefolate calcium A biologically active form of folic acid Levomefolate calcium  Chemical Structure
  15. GC18404 Lometrexol Glycinamide ribonucleotide formyltransferase (GART) is a folate-dependent enzyme required for de novo purine synthesis. Lometrexol  Chemical Structure
  16. GC66387 Lometrexol disodium

    DDATHF disodium

    Lometrexol (DDATHF) disodium, an antipurine antifolate, can inhibit the activity of glycinamide ribonucleotide formyltransferase (GARFT) but do not induce detectable levels of DNA strand breaks. Lometrexol disodium can further inhibit de novo purine synthesis, causing abnormal cell proliferation and apoptosis, even cell cycle arrest. Lometrexol disodium has anticancer activity. Lometrexol disodium also is a potent human Serine hydroxymethyltransferase1/2 (hSHMT1/2) inhibitor. Lometrexol disodium  Chemical Structure
  17. GC39820 Lometrexol hydrate

    DDATHF, (6R)-Dideazatetrahydrofolate

    A GART inhibitor Lometrexol hydrate  Chemical Structure
  18. GC36486 LSN 3213128 LSN 3213128 is a selective, nonclassical, orally bioavailable antifolate with potent and specific inhibitory activity for aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICARFT), with IC50 of 16 nM for AICARFT enzyme inhibiton and 19 nM in cells. Anti-tumor activity. LSN 3213128  Chemical Structure
  19. GC33322 LY 254155 LY 254155, an antifolate, inhibits hGARFT and binds to mFBP with Kis of 2.1±0.2 and 1.7±0.1 nM, respectively. LY 254155  Chemical Structure
  20. GC33373 LY309887 LY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase (GARFT), with a Ki of 6.5 nM, and has antitumor activity. LY309887  Chemical Structure
  21. GC10405 Methotrexate Methotrexate is an antifolate antimetabolite that effectively inhibits the activity of dihydrofolate reductase (DHFR), with an IC50 of approximately 7nM. Methotrexate  Chemical Structure
  22. GC61047 Methotrexate disodium Methotrexate (Amethopterin) disodium, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis. Methotrexate disodium  Chemical Structure
  23. GC36589 Methotrexate metabolite

    DAMPA

    Methotrexate metabolite (DAMPA), the active metabolite of Methotrexate. Methotrexate metabolite  Chemical Structure
  24. GC61058 Metoprine Metoprine (BW 197U) is a potent histamine N-methyltransferase (HMT) inhibitor. Metoprine  Chemical Structure
  25. GC69466 Mirvetuximab

    M9346A

    Mirvetuximab (M9346A) is a monoclonal antibody that targets anti-FOLR1 (folate receptor 1). Mirvetuximab is an antibody molecule for a novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian cancer and other FRα-positive cancer research.

    Mirvetuximab  Chemical Structure
  26. GC73018 Mirvetuximab soravtansine (solution)

    IMGN853 (solution

    Mirvetuximab soravtansine (IMGN853) solution is an anti-folate receptor α (FRα) ADC consisting of the cytotoxic maytansinoid, DM4, covalently linked to the humanized monoclonal antibody M9346A. Mirvetuximab soravtansine (solution)  Chemical Structure
  27. GC11610 Pemetrexed

    Pemetrexed (also known as pemetrexed disodium) is a novel antifolate antimetabolite targeting multiple enzymes involved in both pyrimidine and purine synthesis.

    Pemetrexed  Chemical Structure
  28. GC17694 Pemetrexed disodium hemipenta hydrate Pemetrexed disodium hemipenta hydrate  Chemical Structure
  29. GC12919 Pralatrexate

    NSC 754230, PDX, 10-Propargyl-10-deazaaminopterin

    A dihydrofolate reductase inhibitor Pralatrexate  Chemical Structure
  30. GC17867 Pyrimethamine

    Darapram, Daraprim, Khloridin, NSC 3061

    A dihydrofolate reductase inhibitor Pyrimethamine  Chemical Structure
  31. GC63612 Tetroxoprim Tetroxoprim is an antimicrobial DHFR inhibitor. Tetroxoprim  Chemical Structure
  32. GC10137 Trimethoprim

    NIH 204, NSC 106568

    bacteriostatic antibiotic Trimethoprim  Chemical Structure
  33. GC66422 Trimethoprim-d9 Trimethoprim-d9 is the deuterium labeled Trimethoprim. Trimethoprim is a bacteriostatic antibiotic and an orally active dihydrofolate reductase inhibitor. Trimethoprim is active against a wide range of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim has the potential for urinary tract infections, Shigellosis and Pneumocystis pneumonia treatment. Trimethoprim-d9  Chemical Structure
  34. GC37938 WR99210

    BRL 6231 free base

    WR99210 is an orally active and low-toxicity dihydrofolate reductase (DHFR) inhibitor (IC50<0.075 nM). WR99210  Chemical Structure

33 Item(s)

per page

Set Descending Direction